1. Articles in category: Other Business News

    1-24 of 1162 1 2 3 4 ... 47 48 49 »
    1. ZEISS Marks Milestone for its New North America High Tech Site in Dublin, California

      ZEISS Marks Milestone for its New North America High Tech Site in Dublin, California

      The internationally leading optics and optoelectronics technology enterprise ZEISS completed the “steel topping out” phase of its new high tech site in the San Francisco Bay Area. The new site in Dublin is an integral part of ZEISS’ global investment strategy and is one element in a string of international projects aimed at expanding, modernizing and realigning sites that ZEISS has been implementing in locations such as Germany, Europe and Asia since 2011. “Our investments are focused on leveraging the existing potential in our growth markets,” explains Dr. Christian Mueller, Member of the Executive Board and CFO of the ZEISS ...

      Read Full Article
    2. Lumedica Receives NIH Grant for Low Cost Retinal Optical Coherence Tomography for Point of Care Use

      Lumedica Receives NIH Grant for Low Cost Retinal Optical Coherence Tomography for Point of Care Use

      Lumedica Receives a 2019 NIH Grant for $499,978 for Low Cost Retinal Optical Coherence Tomography for Point of Care Use. The principal investigator is William Brown. The program began in 2016 and ends in 2021. Below is a summary of the proposed work. The objective of this research is to create a clinical prototype of a new optical coherence tomography (OCT) system suitable for diagnostic retinal imaging at the point of care. The target system price will be one third the price of currently available research OCT systems while providing performance comparable to other entry level OCT imaging systems ...

      Read Full Article
    3. ZEISS Ophthalmic Digital Summit 2019

      ZEISS Ophthalmic Digital Summit 2019

      In partnership with ODwire, Carl Zeiss Meditec, Inc. and Carl Zeiss Vision invite you to the ZEISS Ophthalmic Digital Summit 2019 . This two-day complimentary program offers live sessions and an interactive product showcase—all within a virtual exhibit hall—designed to provide you with the latest technology innovations and clinical solutions for your practice. Taught by industry leaders , you'll get trained and informed on how the Integrated Diagnostic Imaging platform and ZEISS leading imaging technologies will help shape the future of your practice. Event attendees will also be eligible for special show promotions and discounts on ZEISS instruments.

      Read Full Article
    4. Avinger Enrolls First 50 Patients in INSIGHT Clinical Trial

      Avinger Enrolls First 50 Patients in INSIGHT Clinical Trial

      Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the 50 th patient enrolled in its INSIGHT clinical trial. The INSIGHT trial is a prospective, global, single arm, multi-center study to evaluate the safety and effectiveness of the Pantheris ® Lumivascular atherectomy system for treating in-stent restenosis (ISR) in lower extremity arteries. Dr. Jaafer Golzar, Avinger’s Chief Medical Officer and a highly experienced interventionalist, noted, “We are pleased to have the first 50 cases completed as part of our INSIGHT IDE study. Early ...

      Read Full Article
      Mentions: Avinger
    5. Avinger Announces Commercial Launch of Ocelot in Australia

      Avinger Announces Commercial Launch of Ocelot in Australia

      First Patients Treated Successfully in Australia with Image-Guided CTO-Crossing Device REDWOOD, CA / ACCESSWIRE / July 8, 2019 / Avinger, Inc. (NASDAQ: AVGR ), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the commercial launch of its Ocelot image-guided chronic total occlusion (CTO) crossing system in Australia. As part of the Company’s exclusive distribution agreement with Diverse Devices Pty Ltd. for Avinger’s proprietary Lumivascular products in Australia, Ocelot completed the registration process with the Therapeutic Goods Administration (TGA) and is included on the Australian Register of Therapeutic ...

      Read Full Article
      Mentions: Avinger
    6. Lumedica Receives $1M Phase II NIH-SBIR Grant, in Support of Detecting Eye Disease Around the World

      Lumedica Receives $1M Phase II NIH-SBIR Grant, in Support of Detecting Eye Disease Around the World

      Lumedica Inc., a privately held company, focused on improving access to eye care by creating low-cost, high performance, Optical Coherence Tomography (OCT) systems for research and clinical applications, received a $1M Phase II NIH-NEI SBIR grant in order to continue system and product development. OCT is considered the gold standard for early detection of Macular Degeneration, Diabetic Retinopathy and Glaucoma, all of which can occur without symptoms. When these diseases are detected early — such as with OCT — they can be managed without patients losing their vision. “We are grateful for the ongoing support from the NIH-NEI, said Principal Investigator and ...

      Read Full Article
      Mentions: Lumedica
    7. PhotoniCare Looks Behind Ear Drums to Help Diagnose Ear Infections

      PhotoniCare Looks Behind Ear Drums to Help Diagnose Ear Infections

      Middle ear infections are one of the most common reasons for visits to the pediatrician. However, because the middle ear is hidden from view by the ear drum, physicians must diagnose based on symptoms and a limited physical exam — and when patients have ambiguous or borderline symptoms, accurate diagnosis can be challenging. PhotoniCare’s TOMi Scope uses near-infrared light waves to provide 3D views beyond the ear drum into the middle ear, allowing physicians to visualize and better diagnose middle ear infections. Co-founder and CEO Ryan Shelton, Ph.D. answered a few of our questions about his company’s beginnings ...

      Read Full Article
    8. Mentice and Siemens Healthineers bring a virtual patient to the angio-suite

      Mentice and Siemens Healthineers bring a virtual patient to the angio-suite

      Siemens Healthineers, a leading medical technology company and Mentice AB, a world leader in simulation solutions for endovascular therapies, announced today the collaboration to fully integrate Mentice’s VIST® Virtual Patient into the Artis icono angiography system from Siemens Healthineers. The VIST® Virtual Patient thus becomes a fully integrated simulation solution for the angio-suite. The global partnership between the two companies will allow interventional radiologists, neuroradiologists, and cardiologists to perform vascular and cardiac interventions on a virtual patient inside the angio-suite. “With an ever-increasing complexity of new interventional procedures, our customers strive to acquire and retain procedural skills while optimizing ...

      Read Full Article
      Mentions: Siemens
    9. New Hope for Port Wine Stain Patients from A Novel Image-Guided Treatment

      New Hope for Port Wine Stain Patients from A Novel Image-Guided Treatment

      Michelson Diagnostics Ltd. (MDL) announces increased outcome benefits from a powerful new treatment approach for patients with Port Wine Stain birthmarks and other disfiguring conditions of the superficial blood vessels in skin, such as hemangiomas, rosacea and spider veins. The novel technique, known as OCT image-guided treatment, utilizes a high-resolution laser scanner to detect and image the tiny blood vessels in the skin, so that the depth, diameter and density of these vessels can be accurately characterized. This information is crucial for optimizing the settings for laser or Broadband Light (BBL) treatments, so that diseased and abnormal vessels are destroyed ...

      Read Full Article
    10. Two thousand optometrists geared up for OCT at Specsavers

      Two thousand optometrists geared up for OCT at Specsavers

      More than 2000 optometrists at Specsavers have completed an extensive programme of Optical Coherence Tomography (OCT) training, ahead of the installation of the hospital-grade technology in their stores. The milestone has been reached almost half way through the rollout across the UK and Ireland of OCT, which is now in use in 400 stores. Richard Davies of the Bath store was the 2000 th optometrist to complete the set of seven online modules, which cover essentials of OCT, OCT in glaucoma, medical retina and anterior segment, and prudent referrals. Presenting a £100 voucher to Richard in store this week, Paul ...

      Read Full Article
    11. Carl Zeiss Meditec expands leadership position in treating glaucoma by investing in MicroOptx, Inc.

      Carl Zeiss Meditec expands leadership position in treating glaucoma by investing in MicroOptx, Inc.

      Today, Carl Zeiss Meditec announced that it has become a shareholder of MicroOptx Inc., headquartered in Minneapolis, MN. MicroOptx is a privately held company focused on innovative minimally invasive glaucoma surgery (MIGS) devices for surgical treatment of glaucoma. Their surgical technology is designed to provide effective reduction of intraocular pressure (IOP) with a simple surgical procedure. ZEISS supports breakthrough surgical treatments for glaucoma and believes MicroOptx’s MIGS solution will complement our leading portfolio of equipment and consumables in ophthalmic surgery. “The investment in MicroOptx will give ZEISS an early position in this new technology designed to increase MIGS adoption ...

      Read Full Article
    12. 3D Printer Powered by Machine Vision and Artificial Intelligence

      3D Printer Powered by Machine Vision and Artificial Intelligence

      Objects made with 3D printing can be lighter, stronger, and more complex than those produced through traditional manufacturing methods. But several technical challenges must be overcome before 3D printing transforms the production of most devices. ADVERTISEMENT Commercially available printers generally offer only high-speed, high-precision, or high-quality materials. Rarely do they offer all three, limiting their usefulness as a manufacturing tool. Today, 3D printing is used mainly for prototyping and low-volume production of specialized parts. Now Inkbit, a startup out of MIT, is working to bring all of the benefits of 3D printing to a slew of products that have never ...

      Read Full Article
      Mentions: Inkbit
    13. SID DisplayWeek a great success for Mirrorcle Technologies

      SID DisplayWeek a great success for Mirrorcle Technologies

      What a show it was! For the first time in company history, the Mirrorcle Technologies team exhibited at the Innovation Zone (or ‘I-Zone’) at the Society for Information Display (‘SID’) DisplayWeek 2019 exhibition in San Jose in early May, showcasing its new RGB Playzer products that are capable of full color projection by combining red, green and blue light sources. Visitors were able to interact with multiple MEMS-mirror based tabletop demos enhanced by additional laser projectors that “drew” colorful vector graphics content onto the carpeted walkways of the I-Zone. At virtually all times, a crowd of interested Silicon Valley movers ...

      Read Full Article
    14. Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device

      Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device

      Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that physicians in 78 clinical sites have successfully treated more than 1,000 patients with the next-generation Pantheris image-guided atherectomy system. The next-generation Pantheris was launched on a limited basis in the U.S. following receipt of 510(k) clearance by the U.S. Food and Drug Administration (FDA) in late May 2018 and features a number of improvements intended to augment the performance and reliability of the product. Importantly ...

      Read Full Article
      Mentions: FDA Avinger
    15. Ping An completes multi-center clinical trials for world's first intelligent OCT retinal disease screening system

      Ping An completes multi-center clinical trials for world's first intelligent OCT retinal disease screening system

      Ping An Insurance (Group) Company of China, Ltd. is pleased to announce that its technology arm, Ping An Technology, has completed a prospective multi-center clinical trial for the world's first intelligent optical coherence tomography (OCT) retinal disease screening system. The screening system is jointly developed by Ping An Technology and US-based Optovue, Inc. It is the first artificial intelligence (AI) imaging and screening system in the world that seamlessly integrates an OCT retinal imaging device and AI lesion detection software. The clinical trial was conducted at three well-known research institutions, the Eye and ENT Hospital of Fudan University in ...

      Read Full Article
    16. EXALOS Introduces RGB Modules for Augmented Reality and Head-up Display Applications

      EXALOS Introduces RGB Modules for Augmented Reality and Head-up Display Applications

      Schlieren, Switzerland, May 6 th , 2019. EXALOS, the world’s leading developer of visible Superluminescent Light Emitting Diodes (SLEDs), has expanded its product porfolio with the introduction of a compact RGB SLED module that will enable the advancement of micro-display architectures for augmented reality (AR) and head-up displays (HUDs). The RGB module constitutes three SLED chips housed in a 14-pin butterfly package (20.8 mm x 1.7 mm) with a total output power of about 30 mW (~ 10 mW/color), which corresponds to a total luminous flux of 5 lm. The individual chips (635 nm (R), 510 nm (G ...

      Read Full Article
      Mentions: Exalos Kevin Hsu
    17. PhotoniCare Inc. Announces Initiation of a Multi-Site Registered Clinical Study in Patients Undergoing Surgery for Chronic Middle Ear Infection

      PhotoniCare Inc. Announces Initiation of a Multi-Site Registered Clinical Study in Patients Undergoing Surgery for Chronic Middle Ear Infection

      PhotoniCare Inc., a medical device company headquartered in Champaign, Illinois, announces successful initiation of a multi-site registered clinical study to evaluate the imaging capabilities and image analysis performance of the PhotoniCare TOMi Scope. Children’s National Health System (Washington, D.C.) is the first initiated of two clinical sites involved in this registered multi-site clinical study, along with Carle Foundation Hospital (Urbana, Illinois). The study is led by Dr. Diego Preciado, Children’s National, and Dr. Ryan Porter, Carle Hospital, along with a team of recognized otitis media experts at both clinical sites. This multi-center study plans to enroll a ...

      Read Full Article
    18. Perimeter Medical Imaging Inc Announces 510(k) Clearance by FDA

      Perimeter Medical Imaging Inc Announces 510(k) Clearance by FDA

      Perimeter Medical Imaging, Inc. (“Perimeter Medical”) announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the second generation of their platform imaging tool used in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization. Enhancements to the newly cleared OTIS™ 2.0 system over the previous generation include: A novel specimen positioning consumable feature Touchscreen interface with improved software, designed to streamline integration with existing clinical workflow 10x faster image acquisition speed Perimeter has developed a world class proprietary reference atlas, with correlations between OTIS ...

      Read Full Article
    19. Avinger Receives FDA Clearance of Pantheris SV Device

      Avinger Receives FDA Clearance of Pantheris SV Device

      Avinger, Inc. ( Nasdaq: AVGR ), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system. Pantheris SV, a product line extension of Avinger’s Lumivascular image-guided atherectomy platform, is expected to expand the available market for Pantheris by up to 50% and allow the Company to address a larger portion of the estimated $500 million atherectomy market. Designed with a lower profile and longer length than ...

      Read Full Article
      Mentions: FDA Avinger
    20. CET of the highest calibre at Optrafair 2019

      CET of the highest calibre at Optrafair 2019

      ‘I came to the Specsavers CET stand at Optrafair last year and I thought it was really good for networking and to keep you in the networking mindset. Also, it’s nice to get CET points! I think right now – because of OCT being quite big – I think it’s important to engage as much as you can because every time you go to the lectures you pick up something new on OCT at the moment. I’m always looking for any kind of help on OCT. I’ve learnt a lot just now in this lecture and I’ve ...

      Read Full Article
      Mentions: Specsavers
    21. Heidelberg Engineering Introduces the GMPE Hood Glaucoma Report for SPECTRALIS® OCT

      Heidelberg Engineering Introduces the GMPE Hood Glaucoma Report for SPECTRALIS® OCT

      New feature of the Glaucoma Module Premium Edition offers an intuitive and accurate approach to aid diagnosis and management of glaucoma Heidelberg Engineering, a privately-held imaging and healthcare IT technologies company focused on ophthalmic diagnostic solutions that empower clinicians to improve patient care, announced today that the Hood Glaucoma Report is now available with a software update within the SPECTRALIS OCT Glaucoma Module Premium Edition (GMPE).” The GMPE Hood Glaucoma Report highlights essential diagnostic information in an intuitive layout that enables a quick, yet comprehensive assessment. Based on the diagnostic approach developed by Donald C. Hood, PhD, this report also ...

      Read Full Article
    22. Optovue Launches New AngioWellness™ Scan at Vision Expo East

      Optovue Launches New AngioWellness™ Scan at Vision Expo East

      Optovue , the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), will launch its new AngioWellness™ scan at Vision Expo East in New York , March 21-24, 2019 . The AngioWellness scan utilizes Optovue's advanced AngioVue ® OCTA technology to quickly assess and diagnose new pathologies in patients, including diabetic patients and those who may be at risk for glaucoma. Sample AngioWellness Report AngioWellness combines structural information on retinal and ganglion cell thickness with objective metrics on retinal vasculature into one easy-to-read report. The first of its kind patient-monitoring tool was designed to help eye care professionals ...

      Read Full Article
      Mentions: Optovue
    23. Conavi Medical Announces Health Canada Approval of Novasight Hybrid System for Visualization During Coronary Angioplasty Procedures

      Conavi Medical Announces Health Canada Approval of Novasight Hybrid System for Visualization During Coronary Angioplasty Procedures

      Conavi Medical Inc. is pleased to announce that it has received a Health Canada Medical Device License for the Novasight Hybrid System. This patented technology is the only clinical system that enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (OCT), and was invented at Sunnybrook Research Institute. Angioplasty and stenting is performed four million times around the world every year as an important part of the treatment of coronary artery disease, including patients suffering from heart attacks and angina. Recent randomized studies with existing IVUS systems have shown that intravascular imaging has the ...

      Read Full Article
    1-24 of 1162 1 2 3 4 ... 47 48 49 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (1 articles) University of Illinois at Urbana-Champaign
  4. People in the News

    1. (1 articles) Stephen A. Boppart
    2. (1 articles) Jon Holmes
    3. (1 articles) Ryan L. Shelton
    4. (1 articles) William J. Brown
  5. OCT Companies in the News

    1. (3 articles) Carl Zeiss Meditec
    2. (2 articles) Avinger
    3. (2 articles) Lumedica
    4. (1 articles) Siemens
    5. (1 articles) Heidelberg Engineering
    6. (1 articles) Michelson Diagnostics
    7. (1 articles) Nidek
    8. (1 articles) Sciton
    9. (1 articles) PhotoniCare
    10. (1 articles) OncoRes Medical
    11. (1 articles) Specsavers
    12. (1 articles) Inkbit